Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
130.28
-2.93 (-2.20%)
At close: Jul 21, 2026, 4:00 PM EDT
130.02
-0.26 (-0.20%)
Pre-market: Jul 22, 2026, 4:05 AM EDT

Gilead Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
161,752152,320115,093100,938107,05591,053
Market Cap Growth
20.16%32.34%14.02%-5.71%17.57%24.63%
Enterprise Value
173,126169,540131,729118,577125,869111,223
Last Close Price
130.28122.7492.3781.0185.8572.61
PE Ratio
17.7218.10243.0818.0023.5914.73
Forward PE
-14.5712.5510.8812.9010.79
PEG Ratio
-0.650.740.938.4241.29
PS Ratio
5.445.174.003.723.923.33
PB Ratio
6.886.715.954.425.044.32
P/FCF Ratio
15.8116.1111.1713.6012.838.43
P/OCF Ratio
14.9715.2010.6312.6111.808.00
EV/Sales Ratio
5.825.764.584.374.614.07
EV/EBITDA Ratio
11.7513.2629.7411.5113.349.29
EV/EBIT Ratio
14.4516.9279.2615.5917.1711.21
EV/FCF Ratio
16.9217.9312.7815.9815.0910.29
Debt / Equity Ratio
0.890.981.291.021.081.20
Debt / EBITDA Ratio
1.691.956.032.432.682.23
Debt / FCF Ratio
2.302.642.593.373.022.47
Net Debt / Equity Ratio
0.620.760.870.780.890.96
Net Debt / EBITDA Ratio
1.111.353.781.722.001.69
Net Debt / FCF Ratio
1.511.831.622.392.261.87
Asset Turnover
0.520.500.470.430.420.40
Inventory Turnover
3.333.583.583.953.624.00
Quick Ratio
1.311.061.201.060.990.95
Current Ratio
1.971.551.601.431.291.27
Return on Equity (ROE)
40.03%40.66%2.29%25.54%21.60%31.57%
Return on Assets (ROA)
15.46%14.75%1.91%9.93%8.78%18.20%
Return on Invested Capital (ROIC)
22.88%22.95%3.02%15.45%14.16%29.73%
Return on Capital Employed (ROCE)
22.06%21.28%3.40%14.80%13.54%17.50%
Earnings Yield
5.70%5.52%0.41%5.55%4.24%6.79%
FCF Yield
6.32%6.21%8.95%7.35%7.79%11.87%
Dividend Yield
2.52%2.62%3.40%3.77%3.44%3.95%
Payout Ratio
43.79%47.04%816.25%67.24%80.77%57.91%
Buyback Yield / Dilution
0.34%0.00%0.24%0.32%0.00%0.08%
Total Shareholder Return
2.86%2.62%3.64%4.08%3.44%4.03%
SEC Filings: 10-K · 10-Q